Versant Ventures V, LLC's Net Worth

$0

Estimate Recalculated Jun 10, 2025 04:31PM EST

Who is Versant Ventures V, LLC?

Versant Ventures V, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., Repare Therapeutics Inc., Aprea Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., and CRISPR Therapeutics AG.

SEC CIK

Versant Ventures V, LLC's CIK is 0001619298

Past Insider Trading and Trends

2021 was Versant Ventures V, LLC's most active year for acquiring shares with 9 total transactions. Versant Ventures V, LLC's most active month to acquire stocks was the month of December. 2021 was Versant Ventures V, LLC's most active year for disposing of shares, totalling 3 transactions. Versant Ventures V, LLC's most active month to dispose stocks was the month of December. 2022 saw Versant Ventures V, LLC paying a total of $0.00 for 141,103 shares, this is the most they've acquired in one year. In 2022 Versant Ventures V, LLC cashed out on 141,103 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.30%
-22.84K
$50.90
-$1,164,655.40
1.73M
Scheduled
Apr 24
Form 4
-33.33%
-2.30M
—
—
4.61M
Sep 5
No matching records found

Turnstone Biologics Corp. (TSBX) Snapshot price: $0.5884

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.38M
$12.00
—
3.38M
Jul 25
Form 3
—
0
—
—
0
No matching records found

Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.54%
-1.45M
$12.25
-$9,188,775.00
4.98M
Jun 3 - Jun 6
Form 4
-39.68%
-152.07K
—
—
231.21K
Scheduled
Aug 5
Form 4
-16.37%
-75.00K
—
—
383.28K
Jun 1
Form 4
-9.99%
-240.75K
—
—
2.17M
Scheduled
May 5
Form 4
-10.29%
-350.00K
—
—
3.05M
Scheduled
Feb 16
Form 4
-9.36%
-600.00K
—
—
5.81M
Scheduled
Jan 29
Form 4
-7.23%
-500.00K
—
—
6.41M
Scheduled
Jan 14
Form 4
-10.12%
-325.00K
—
—
2.88M
Scheduled
Dec 15
Form 4
+64.65%
6.5M
$20.00
$5,000,000.00
16.54M
Jun 23
Form 3
—
0
—
—
0
No matching records found

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.00%
-507.59K
—
—
2.88M
Feb 4
No matching records found

Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.50%
-881.76K
—
—
4.16M
Apr 9 - May 18
Form 4
+22,415.04%
2.84M
$15.00
$4,999,995.00
2.85M
Oct 7
Form 3
—
0
—
—
0
No matching records found